- £237.55m
- £212.75m
- £83.01m
- 97
- 55
- 22
- 61
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 78.6 | 77.2 | 67.3 | 75.2 | 83 |
Cost of Revenue | |||||
Gross Profit | 46.7 | 45 | 39.1 | 46.2 | 53 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 57.9 | 57.9 | 50.9 | 55.1 | 61.5 |
Operating Profit | 20.7 | 19.3 | 16.4 | 20.1 | 21.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 21 | 18.6 | 15.8 | 19.5 | 21.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17 | 15 | 13 | 15.5 | 17 |
Net Income Before Extraordinary Items | |||||
Net Income | 17 | 15 | 13 | 15.5 | 17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17 | 15 | 13 | 15.5 | 17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.392 | 0.346 | 0.267 | 0.349 | 0.394 |
Dividends per Share | |||||
Special Dividends per Share |